Advertisement

Importance of the Madras Diabetes Research Foundation-Indian Diabetes Risk Score (MDRF-IDRS) for mass screening of type 2 diabetes and its complications at primary health care centers of North India

  • Mohammad Mustufa Khan
  • Gyanendra Kumar SonkarEmail author
  • Sangeeta Singh
  • Satyendra Kumar Sonkar
Review Article
  • 9 Downloads

Abstract

Diabetes in combination with abdominal obesity and hypertension is the leading cause of cardiovascular diseases (CVD) and death. Type 2 diabetes (T2DM) increases CVD risk in two- to fourfold. The prevalence of CVD is constantly rising in India and is higher in urban areas. In addition, more than 50% of diabetic patients are still undiagnosed in the general population. The Madras Diabetes Research Foundation-Indian Diabetes Risk Score (MDRF-IDRS) is a cost-effective and very simple tool, which can be used at a primary health care center routinely. It is observed that people with increasing age, sedentary lifestyle, greater abdominal obesity, and family history of diabetes are at a high risk for diabetes and its complications. MDRF-IDRS is helpful for mass screening of diabetes and its complications in North Indian population to prevent the incidence of diabetes and with lifestyle interventions, knowledge, and awareness, it helps to reduce and revert the complications of diabetes. It is suggested that regular practice of MDRF-IDRS-based screening at primary health care center may also reduce the burden at the critical care center in North India.

Keywords

Diabetes Cardiovascular disease MDRF-IDRS Life style intervention Primary health care center Critical care center 

Notes

References

  1. 1.
    IDF: International Diabetes Federation. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015.Google Scholar
  2. 2.
    Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, et al. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR–INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5:585–96.  https://doi.org/10.1016/S2213-8587(17)30174-2.CrossRefPubMedGoogle Scholar
  3. 3.
    Joshi SR, Das AK, Vijay VJ, Mohan V. Challenges in diabetes care in India: sheer numbers, lack of awareness and inadequate control. J Assoc Physicians India. 2008;56:443–50.PubMedGoogle Scholar
  4. 4.
    Mohan V, Sandeep S, Deepa M, Gokulakrishnan K, Datta M, Deepa R. A diabetes risk score helps identify metabolic syndrome and cardiovascular risk in Indians-the Chennai Urban Rural Epidemiology Study (CURES-38). Diabetes Obes Metab. 2007;9:337–43.CrossRefGoogle Scholar
  5. 5.
    Raoa M, Xavier D, Devi P, Sigamani A, Faruqui A, Gupta R, et al. Prevalence, treatments and outcomes of coronary artery disease in Indians: a systematic review. Indian Heart J. 2015;67:302–10.CrossRefGoogle Scholar
  6. 6.
    Mohan V, Deepa R, Rani SS, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India. The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 2001;38(3):682–7.CrossRefGoogle Scholar
  7. 7.
    Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr. 2017;9:25.CrossRefGoogle Scholar
  8. 8.
    WHO: World Health Organization, World Health Day: WHO Calls for global action to halt rise in and improve care for people with diabetes. World Health Organization; 2016. Available from: http://www.who.int/mediacentre/news/releases/2016/world-health-day/en/. [Last accessed on 2016 Apr 06].
  9. 9.
    Sharma KM, Ranjani H, Zabetian A, Datta M, Deepa M, Moses CRA, et al. Excess cost burden of diabetes in Southern India: a clinic-based, comparative cost-of-illness study. Glob Health Epidemiol Genomics. 2016;1(e8):1–8.  https://doi.org/10.1017/gheg.2016.2.CrossRefGoogle Scholar
  10. 10.
    Mohan V, Deepa R, Deepa M, Somannavar S, Datta M. A simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759–63.PubMedGoogle Scholar
  11. 11.
    Mohan V, Mathur P, Deepa R, Deepa M, Shukla DK, Menon GR, et al. Urban rural differences in prevalence of self-reported diabetes in India – the WHO-ICMR Indian NCD risk factor surveillance. Diabetes Res Clin Pract. 2008;80:159–68.CrossRefGoogle Scholar
  12. 12.
    Gupta SK, Singh Z, Purty AJ, Vishwanathan M. Diabetes prevalence and its risk factors in urban Pondicherry. Int J Diabetes Dev Ctries. 2009;29:166–9.CrossRefGoogle Scholar
  13. 13.
    Gupta SK, Singh Z, Purty AJ, Kar M, Vedapriya D, Mahajan P, et al. Diabetes prevalence and its risk factors in rural area of Tamil Nadu. Indian J Community Med. 2010;35:396–9.CrossRefGoogle Scholar
  14. 14.
    Gore CA, Subramanian M. Diabetes risk in an urban slum population in Bangalore, India. Int J Prevent Public Health Sci. 2016;1(6):11–4.Google Scholar
  15. 15.
    Patil RS, Gothankar JS. Assessment of risk of type 2 diabetes using the Indian diabetes risk score in an urban slum of Pune, Maharashtra, India: a cross-sectional study. WHO South-East Asia J Public Health. 2016;5(1):53–61.CrossRefGoogle Scholar
  16. 16.
    Turale AD, Khandekar V, Patrikar VG. Indian diabetes risk score for screening of undiagnosed pre-diabetic individuals of Sakkardara region of Nagpur City. Int Ayurvedic Med J. 2017;5(10):3722–5.Google Scholar
  17. 17.
    Agarwal AK, Ahirwar G, Marskole P, Bhagwat AK. A community based study to assess the validity of Indian diabetic risk score, among urban population of North Central India. Int J Community Med Public Health. 2017;4:2101–6.CrossRefGoogle Scholar
  18. 18.
    Nanandeshwar S, Jamra V, Pal DK. Indian diabetic risk score for screening of undiagnosed diabetic subjects of Bhopal city. Natl J Community Med. 2010;1(2):176–7.Google Scholar
  19. 19.
    Khan MM, Sonkar GK, Alam R, Mehrotra S, Khan MS, Kumar A, et al. Validity of Indian Diabetes Risk Score and its association with body mass index and glycosylated hemoglobin for screening of diabetes in and around areas of Lucknow. J Family Med Prim Care. 2017;6:366–73.CrossRefGoogle Scholar
  20. 20.
    Acharya AS, Singh A, Dhiman B. Assessment of diabetes risk in an adult population using Indian Diabetes Risk Score in an urban resettlement colony of Delhi. J Assoc Physicians India. 2017;65:46–51.PubMedGoogle Scholar
  21. 21.
    Rajput M, Garg D, Rajput R. Validation of simplified Indian Diabetes Risk Score for screening undiagnosed diabetes in an urban setting of Haryana. Diab Met Syndr Clin Res Rev. 2017;11:S539–42.  https://doi.org/10.1016/j.dsx.2017.03.048.CrossRefGoogle Scholar
  22. 22.
    Kaushal K, Mahajan A, Parashar A, Dhadwal DS, Jaswal V, Jaret P, et al. Validity of madras diabetes research foundation: Indian diabetes risk score for screening of diabetes mellitus among adult population of urban field practice area, Indira Gandhi Medical College, Shimla, Himachal Pradesh, India. Indian J Endocr Metab. 2017;21:876–81.CrossRefGoogle Scholar
  23. 23.
    Gupta RK, Shora TN, Verma AK, Raina SK. Utility of MDRF-IDRS (Madras Diabetes Research Foundation-Indian Diabetes Risk Score) as a tool to assess risk for diabetes—a study from north-west India. Int J Diabetes Dev Ctries. 2015;35(4):570–2.CrossRefGoogle Scholar
  24. 24.
    Chowdhury R, Mukherjee A, Lahiri SK. A study on distribution and determinants of Indian Diabetic Risk Score (IDRS) among rural population of West Bengal. Natl J Med Res. 2012;2(3):282–6.Google Scholar
  25. 25.
    Mohan V, Vassy JL, Pradeepa R, Deepa M, Subashini S. The Indian type 2 diabetes risk score also helps identify those at risk of macrovasvular disease and neuropathy (CURES-77). J Assoc Physicians India. 2010;58:430–3.PubMedGoogle Scholar
  26. 26.
    Jain A, Paranjape S. Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: an ideal facility. Indian J Endocrinol Metab. 2013;17(Suppl 1):S318–22.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Palta P, Huang ES, Kalyani RR, Golden SH, Yeh HC. Hemoglobin A1C and mortality in older adults with and without diabetes: results from the National Health and nutrition examination surveys (1988–2011). Diabetes Care. 2017;40:453–60.CrossRefGoogle Scholar
  28. 28.
    Kilkenny MF, Dunstan L, Busingye D, Purvis T, Reyneke M, Orgill M, et al. Knowledge of risk factors for diabetes or cardiovascular disease (CVD) is poor among individuals with risk factors for CVD. PLoS One. 2017;12(2):e0172941.CrossRefGoogle Scholar
  29. 29.
    Dhana K, Koolhaas CM, van Rossum EFC, Ikram MA, Hofman A, Kavousi M, et al. Metabolically healthy obesity and the risk of cardiovascular disease in the elderly population. PLoS One. 2016;11(4):e0154273.CrossRefGoogle Scholar
  30. 30.
    Srinivasan MP, Kamath PK, Bhat NM, Pai ND, Bhat RU, Shah TD, et al. Severity of coronary artery disease in type 2 diabetes mellitus: does the timing matter? Indian Heart J. 2016;68(2):158–63.CrossRefGoogle Scholar
  31. 31.
    Qi Q, Meigs JB, Rexrode KM, Hu FB, Qi L. Diabetes genetic predisposition score and cardiovascular complications among patients with type 2 diabetes. Diabetes Care. 2013;36(3):737–9.CrossRefGoogle Scholar
  32. 32.
    Bennet L, Lindblad U, Franks PW. A family history of diabetes determines poorer glycaemic control and younger age of diabetes onset in immigrants from the Middle East compared with native swedes. Diabetes Metab. 2015;41:45–54.CrossRefGoogle Scholar
  33. 33.
    Park GM, Cho YR, Lee SW, Yun SC, Gil EH, Kim DW, et al. Family history of diabetes and the risk of subclinical atherosclerosis. Diabetes Metab. 2016;42(3):170–7.CrossRefGoogle Scholar
  34. 34.
    Park JW, Yun JE, Park T, Cho E, Jee SH, Jang Y, et al. Family history of diabetes and risk of atherosclerotic cardiovascular disease in Korean men and women. Atherosclerosis. 2008;197:224–31.CrossRefGoogle Scholar
  35. 35.
    Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ. Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med. 2006;8(2):102–8.CrossRefGoogle Scholar
  36. 36.
    Zhao Y, Song C, Ma X, Ma X, Wang Q, Ji H, et al. Synergistic effect of family history of diabetes and dietary habits on the risk of type 2 diabetes in Central China. Int J Endocrinol. 2017:Article ID 9707284:8.Google Scholar
  37. 37.
    Marinou K, Hodson L, Vasan SK, Fielding BA, Banerjee R, Brismar K, et al. Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men. Diabetes Care. 2014;37:821–9.CrossRefGoogle Scholar
  38. 38.
    Anand SS, Tarnopolsky MA, Rashid S, Schulze KM, Desai D, Mente A, et al. Adipocyte hypertrophy, fatty liver and metabolic risk factors in south Asians: the molecular study of health and risk in ethnic groups (Mol-SHARE). PLoS One. 2011;6:e22112.CrossRefGoogle Scholar
  39. 39.
    Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86:5366–71.CrossRefGoogle Scholar
  40. 40.
    Anoop S, Misra A, Mani K, Pandey RM, Gulati S, Bhatt SP, et al. Estimation of liver span using MRI for prediction of type 2 diabetes in non-obese Asian Indians. J Diabetes Sci Technol. 2017;11:446–7.CrossRefGoogle Scholar
  41. 41.
    Deepa M, Farooq S, Deepa R, Manjula D, Mohan V. Prevalence and significance of generalized and central body obesity in an urban Asian Indian population in Chennai, India (CURES: 47). Eur J Clin Nutr. 2009;63:259–67.CrossRefGoogle Scholar
  42. 42.
    World Health Organization (WHO). The Asia Pacific perspective. Redefining obesity and its treatment. International Association for the Study of Obesity and International Obesity Task Force. Melbourne: International Diabetes Institute; 2000.Google Scholar
  43. 43.
    World Health Organization (WHO) Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRefGoogle Scholar
  44. 44.
    Pradeepa R, Anjana RM, Joshi SR, Bhansali A, Deepa M, Joshi PP, et al. Prevalence of generalized and abdominal obesity in urban and rural India – the ICMR-INDIAB study (phase-I) [ICMR-NDIAB-3]. Indian J Med Res. 2015;142:139–50.CrossRefGoogle Scholar
  45. 45.
    Fan H, Li X, Zheng L, Chen X, Lan Q, Wu H, et al. Abdominal obesity is strongly associated with Cardiovascular disease and its risk factors in elderly and very elderly community-dwelling Chinese. Sci Repo. 2016;6:21521.CrossRefGoogle Scholar
  46. 46.
    WHO: World Health Organization. Waist circumference and waist–hip ratio: report of a WHO expert consultation Geneva, 8–11 December 2008. Available from http://apps.who.int/iris/bitstream/10665/44583/1/9789241501491_eng.pdf [Last Accessed on 2018 Jan 21].
  47. 47.
    Kim MK, Lee WY, Kang JH, Kang JH, Kim BT, Kim SM, et al. 2014 clinical practice guidelines for overweight and obesity in Korea. Endocrinol Metab (Seoul). 2014;29:405–9.CrossRefGoogle Scholar
  48. 48.
    Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133:639–49.CrossRefGoogle Scholar
  49. 49.
    Gulati S, Misra A. Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake. Eur J Clin Nutr. 2017;71:850–7.CrossRefGoogle Scholar
  50. 50.
    Anjana RM, Pradeepa R, Das AK, Deepa M, Bhansali A, Joshi SR, et al. Physical activity and inactivity patterns in India – results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]. Int J Behav Nutr Phys Act. 2014;11:26.CrossRefGoogle Scholar
  51. 51.
    WHO: World Health Organization. Cardiovascular diseases (CVDs). Fact sheet Updated May 2017. World Health Organization, Geneva. Available from http://www.who.int/mediacentre/factsheets/fs317/en/ [Last accessed on 2018 Jan 21].
  52. 52.
    WHO: World Health Organization. Physical activity fact sheet. Last updated February 2017 World Health Organization. Geneva. http://www.who.int/mediacentre/factsheets/fs385/en/[Last Accessed on 2018 Jan 21].
  53. 53.
    Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation. 2003;107(19):2435–9.CrossRefGoogle Scholar
  54. 54.
    Wahid A, Manek N, Nichols M, Kelly P, Foster C, Webster P, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5(9):e002495.CrossRefGoogle Scholar
  55. 55.
    Deepa M, Anjana RM, Mohan V. Role of lifestyle factors in the epidemic of diabetes: lessons learnt from India. Eur J Clin Nutr. 2017;71:825–31.CrossRefGoogle Scholar
  56. 56.
    Hamasaki H. Daily physical activity and type 2 diabetes: a review. World J Diabetes. 2016;7(12):243–51.CrossRefGoogle Scholar
  57. 57.
    Li W, Wang D, Wu C, Shi O, Zhou Y, Lu Z. The effect of body mass index and physical activity on hypertension among Chinese middle-aged and older population. Sci Rep. 2017;7:10256.  https://doi.org/10.1038/s41598-017-11037-y.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Paley CA, Johnson MI. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabil. 2018;10:7.CrossRefGoogle Scholar
  59. 59.
    Caro JJ, Ward AJ, O’Brien JA. Lifetime costs of complications resulting from type 2 diabetes in the U.S. Diabetes Care. 2002;25:476–81.CrossRefGoogle Scholar
  60. 60.
    O’Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther. 2003;25:1017–38.CrossRefGoogle Scholar
  61. 61.
    Falciglia M, Freyberg RW, Almenoff PL, D’Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001–9.CrossRefGoogle Scholar
  62. 62.
    Maniarasu K, Muthunarayanan L. Prevalence of certain chronic complications of diabetes among type 2 diabetic patients in rural population of Kancheepuram District, Tamil Nadu- a cross sectional study. Int J Med Public Health. 2017;7(1):41–6.CrossRefGoogle Scholar
  63. 63.
    Mokta J, Mokta K, Ranjan A, Garg M. Prevalence of cardiovascular risk factors among diabetic population and awareness of diabetes among diabetic patients: a population based Himalayan study. J Assoc Physicians India. 2017;65(2):48–52.PubMedGoogle Scholar
  64. 64.
    Tripathy JP, Thakur JS, Jeet G, Chawla S, Sanjay Jain S, Pal A, et al. Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India. Diabetol Metab Syndr. 2017;9:8.CrossRefGoogle Scholar
  65. 65.
    Joshi SR. Diabetes Care in India. Ann Glob Health. 2015;81(6):830–8.CrossRefGoogle Scholar
  66. 66.
    Decode study group; on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397–405.CrossRefGoogle Scholar
  67. 67.
    Mohan V, Anbalagan VP. Expanding role of the madras diabetes research foundation – Indian diabetes risk score in clinical practice. Indian J Endocrinol Metab. 2013;17:31–6.CrossRefGoogle Scholar
  68. 68.
    Gokulakrishnan K, Ranjani H, Weber MB, Pandey GK, Anjana RM, Balasubramanyam M, et al. Effect of lifestyle improvement program on the biomarkers of adiposity, inflammation and gut hormones in overweight/obese Asian Indians with prediabetes. Acta Diabetol. 2017;54:843–52.  https://doi.org/10.1007/s00592-017-1015-9.CrossRefPubMedGoogle Scholar
  69. 69.
    Sukla P, Shrivastava SRBL, Prateek Saurabh Shrivastava PS. A longitudinal study to assess the impact of exercise on clinical, biochemical, and anthropometric parameters among the type 2 diabetes patients of South India. Avicenna J Med. 2015;5(1):16–20.CrossRefGoogle Scholar
  70. 70.
    Cárdenas FG, Bawaked RA, Martínez GMÁ, Corella D, Subirana CI, Salas-Salvadó J, et al. Association of physical activity with body mass index, waist circumference and incidence of obesity in older adults. Eur J Pub Health. 2018;28(5):944–50.CrossRefGoogle Scholar
  71. 71.
    Barik A, Mazumdar S, Chowdhury A, Rai RK. Physiological and behavioral risk factors of type 2 diabetes mellitus in rural India. BMJ Open Diabetes Research and Care. 2016;4:e000255.  https://doi.org/10.1136/bmjdrc-2016-000255.CrossRefPubMedGoogle Scholar
  72. 72.
    Stanford KI, Goodyear LJ. Exercise and type 2 diabetes: molecular mechanisms regulating glucose uptake in skeletal muscle. Adv Physiol Educ. 2014;38(4):308–14.CrossRefGoogle Scholar
  73. 73.
    Way KL, Hackett DA, Baker MK, Johnson NA. The effect of regular exercise on insulin sensitivity in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab J. 2016;40:253–71.CrossRefGoogle Scholar
  74. 74.
    Lee B, Shao J. Adiponectin and energy homeostasis. Rev Endocr Metab Disord. 2014;15(2):149–56.CrossRefGoogle Scholar
  75. 75.
    Højbjerre L, Sonne MP, Alibegovic AC, Nielsen NB, Dela F, Vaag A, et al. Impact of physical inactivity on adipose tissue low-grade inflammation in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2011;34:2265–72.CrossRefGoogle Scholar
  76. 76.
    Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol. 1998;8:335–8.CrossRefGoogle Scholar

Copyright information

© Research Society for Study of Diabetes in India 2019

Authors and Affiliations

  1. 1.School of Biological Engineering and SciencesShobhit UniversitySaharanpurIndia
  2. 2.Department of BiochemistryKing George’s Medical UniversityLucknowIndia
  3. 3.Department of MedicineKing George’s Medical UniversityLucknowIndia

Personalised recommendations